US HB7377 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on April 4 2022 - 25% progression, died in committee
Action: 2022-04-05 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 4 2022 - 25% progression, died in committee
Action: 2022-04-05 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to modernize therapeutic equivalence rating determinations.
Title
Modernizing Therapeutic Equivalence Rating Determination Act
Sponsors
| Rep. John Curtis [R-UT] | Rep. Angela Craig [D-MN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-04-05 | House | Referred to the Subcommittee on Health. |
| 2022-04-04 | House | Referred to the House Committee on Energy and Commerce. |
| 2022-04-04 | House | Introduced in House |
Same As/Similar To
SB1463 (Same As) 2021-04-29 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/7377/all-info |
| Text | https://www.congress.gov/117/bills/hr7377/BILLS-117hr7377ih.pdf |
